Table I.
Relationship between clinicopathological features and β-catenin expression in patients with pleomorphic adenoma.
| Clinicopathological features | No. of patients | β-catenin expression
|
P-value | |
|---|---|---|---|---|
| Negative (n=5) | Positive (n=14) | |||
| Gender | NS | |||
| Male | 8 | 3 (37.5) | 5 (62.5) | |
| Female | 11 | 2 (18.2) | 9 (81.8) | |
| Age | 44.2±3.5 | 44.0±9.8 | 44.3±3.6 | NS |
| Tumor location | NS | |||
| Palate | 9 | 2 (22.2) | 7 (77.8) | |
| Parotid | 3 | 1 (33.3) | 2 (66.7) | |
| Submandibular | 3 | 1 (33.3) | 2 (66.7) | |
| Oral mucosa | 3 | 1 (33.3) | 2 (66.7) | |
| Minor salivary gland | 1 | 0 (0.0) | 1 (100.0) | |
| Stage | NS | |||
| I | 7 | 2 (28.6) | 5 (71.4) | |
| II | 10 | 3 (30.0) | 7 (70.0) | |
| III | 2 | 0 (0.0) | 2 (100.0) | |
| Tumor size | 33.2±9.6 | 24.6±4.7 | 36.2±13.0 | NS |
NS, not significant.